Summary
Total cholesterol is the combined measure of all cholesterol in the blood — including LDL ('bad'), HDL ('good'), and VLDL. While a single total cholesterol number is useful for initial cardiovascular screening, it must be interpreted alongside HDL, LDL, non-HDL cholesterol, and triglycerides for an accurate picture of heart disease risk. High total cholesterol with high HDL carries very different risk from the same level with low HDL.
Cholesterol is a waxy fat essential for building cell membranes, synthesising steroid hormones and vitamin D, and producing bile acids. The liver produces approximately 75% of total body cholesterol; the remaining 25% comes from diet.
In the UK, a desirable total cholesterol is below 5.0 mmol/L for general adults and below 4.0 mmol/L for people with established cardiovascular disease or diabetes. Cholesterol-lowering medication (statins) reduces total cholesterol and LDL, but the cardiovascular benefit comes specifically from LDL reduction — not total cholesterol reduction per se.
Total cholesterol should always be interpreted in the context of the full lipid profile (LDL, HDL, non-HDL, triglycerides) and overall cardiovascular risk (age, sex, blood pressure, smoking, diabetes).
What It Is
Cholesterol is a 27-carbon sterol carried through the bloodstream in lipoprotein particles. Total cholesterol = LDL-C + HDL-C + VLDL-C (VLDL ≈ triglycerides ÷ 5 in most cases). It is measured enzymatically via the Trinder reaction.
The major carriers of cholesterol in the blood are low-density lipoprotein (LDL), which delivers cholesterol to peripheral tissues and arterial walls; high-density lipoprotein (HDL), which transports excess cholesterol back to the liver for excretion (reverse cholesterol transport); and very-low-density lipoprotein (VLDL), which carries triglycerides from the liver.
UK NICE guidelines use total cholesterol as a component of QRISK3 cardiovascular risk scoring alongside other clinical variables, but favour LDL and non-HDL as the primary treatment targets.
Functions
Cardiovascular risk screening
Total cholesterol is the primary initial cardiovascular screening marker — the starting point for lipid risk assessment.
Cell membrane component
Cholesterol is a critical structural component of every cell membrane, regulating fluidity, signal transduction, and protein function.
Hormone synthesis precursor
All steroid hormones (cortisol, oestradiol, testosterone, aldosterone) are synthesised from cholesterol — adequate levels are essential for hormonal health.
Bile acid and vitamin D production
Cholesterol is the precursor for bile acids (essential for fat digestion) and for the skin's synthesis of vitamin D from sunlight.
Reference Ranges
Total Serum Cholesterol
Measured in mmol/L| Status | Range (mmol/L) | Range (mg/dL) | What it means |
|---|---|---|---|
| Optimal | < 5.0 | < 193 | Desirable total cholesterol for general cardiovascular prevention. |
| Borderline | 5.0–6.4 | 193–247 | Mildly elevated — review full lipid profile and cardiovascular risk factors. |
| High | ≥ 6.5 | ≥ 250 | Significantly elevated — full cardiovascular risk assessment and management required. |
Total cholesterol must be interpreted alongside HDL, LDL, and non-HDL. NICE recommends a target < 4.0 mmol/L for those with existing cardiovascular disease. Treat the overall risk, not the number in isolation.
Symptoms of Imbalance
Elevated cholesterol is entirely asymptomatic in most people — cardiovascular risk builds silently for decades.
- Very low total cholesterol (< 3.0 mmol/L) is associated with haemorrhagic stroke risk and may indicate malnutrition or liver disease
- Symptoms of the underlying condition causing very low cholesterol
- Usually asymptomatic
- Xanthelasma (yellowish plaques around the eyelids) in severe hypercholesterolaemia
- Tendon xanthomata (nodules over Achilles tendons and knuckles) in familial hypercholesterolaemia
- Corneal arcus (white ring at the edge of the cornea) in younger adults with FH
Causes of Imbalance
- Malnutrition and severe weight loss
- Hyperthyroidism (increases cholesterol clearance)
- Liver failure (impaired cholesterol synthesis)
- Malabsorption syndromes
- Statin therapy (intended reduction)
- Familial hypercholesterolaemia (genetic — affects 1 in 250 UK adults)
- Unhealthy diet (high in saturated and trans fats)
- Sedentary lifestyle and obesity
- Hypothyroidism (reduces hepatic LDL receptor expression)
- Type 2 diabetes and insulin resistance
- Chronic kidney disease
- Medications: corticosteroids, thiazides, progestins
FAQs
No — cholesterol is essential for life. Every cell membrane contains cholesterol; it is the precursor for all steroid hormones, bile acids, and vitamin D. The cardiovascular risk comes specifically from elevated LDL cholesterol, which promotes atherosclerosis, and from oxidised LDL in the context of inflammation. HDL cholesterol is protective. The total:HDL ratio (or non-HDL cholesterol) is a far better cardiovascular risk indicator than total cholesterol alone.
Dietary saturated fat raises LDL cholesterol — replacing saturated with unsaturated fats (olive oil, nuts, oily fish) reduces LDL by approximately 5–15%. Dietary cholesterol itself has less impact than previously thought. Trans fats (found in some processed foods) raise LDL and lower HDL — the worst combination — and should be avoided entirely. Soluble fibre (oats, barley, legumes) reduces LDL by binding bile acids in the gut.
The decision to start a statin is based on your 10-year cardiovascular event risk (QRISK3 score), not just your cholesterol level. NICE recommends offering statin therapy when the 10-year CVD risk exceeds 10%. Statins reduce LDL by 30–50% and reduce cardiovascular events by a similar proportion — but the absolute benefit depends on your baseline risk. Discuss with your GP.
FH is a genetic condition affecting approximately 1 in 250 people in the UK, caused by mutations in the LDL receptor gene. Affected individuals have LDL levels 2–3 times normal from birth, leading to premature coronary artery disease (often before age 50 in untreated cases). Total cholesterol > 7.5 mmol/L, family history of early heart disease, and tendon xanthomata are classic features. Cascade screening of first-degree relatives is recommended once a case is identified.
The liver produces approximately 75% of total cholesterol independently of diet. In familial hypercholesterolaemia, the liver cannot clear LDL efficiently due to faulty LDL receptors, causing high cholesterol regardless of diet. Hypothyroidism, kidney disease, and some medications also raise cholesterol independent of dietary intake. If lifestyle changes have not normalised your cholesterol, investigation for secondary causes and genetic conditions is worthwhile.
References
- NICE. Cardiovascular disease: risk assessment and reduction, including lipid modification. CG181. Updated 2023. View source
- Grundy SM, et al. 2018 AHA/ACC guideline on the management of blood cholesterol. Circulation. 2019;139(25):e1082–e1143. View source
- Ference BA, et al. Low-density lipoproteins cause atherosclerotic cardiovascular disease. Eur Heart J. 2017;38(32):2459–2472. View source